Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Xiuli Tao"'
Autor:
Qian Zhang, Xiuli Tao, Pei Yuan, Zewei Zhang, Jianming Ying, Lei Guo, Ning Li, Shuhang Wang, Jing Li, Ying Liu, Wei Guo, Shijun Zhao, Ning Wu
Publikováno v:
Cancer Medicine, Vol 12, Iss 22, Pp 20864-20877 (2023)
Abstract Purpose To investigate the correlations between metabolic parameters (MPs) of 18F‐fluorodeoxyglucose (FDG) uptake on positron emission tomography/computed tomography (PET/CT), serum tumor markers (STMs), and tumor mutational burden (TMB) i
Externí odkaz:
https://doaj.org/article/3c481717169c488ca2671e2293cbee2f
Autor:
Shuhang Wang, Pei Yuan, Beibei Mao, Ning Li, Jianming Ying, Xiuli Tao, Wei Tang, Lei Zhang, Xiao Geng, Fan Zhang, Qi Xue, Lijia Wu, Henghui Zhang, Shugeng Gao, Jie He
Publikováno v:
npj Precision Oncology, Vol 6, Iss 1, Pp 1-8 (2022)
Abstract Several clinical trials have shown the safety and effectiveness of PD-1/PD-L1 inhibitors in neoadjuvant therapy in resectable non-small cell lung cancer (NSCLC). However, 18–83% patients can benefit from it. In this study, we aimed to asse
Externí odkaz:
https://doaj.org/article/5bc25900f6024bea9b9d2581dfdd2d60
Autor:
Donghui Hou, Xiaomin Zheng, Wei Song, Xiaoqing Liu, Sicong Wang, Lina Zhou, Xiuli Tao, Lv Lv, Qi Sun, Yujing Jin, Zewei Zhang, Lieming Ding, Ning Wu, Shijun Zhao
Publikováno v:
Thoracic Cancer, Vol 12, Iss 17, Pp 2388-2399 (2021)
Abstract Background Here, we aimed to assess the association of ALK variants and alterations with ensartinib response duration in NSCLC, and explore the potential value of computed tomography (CT) radiomic features in predicting progression‐free su
Externí odkaz:
https://doaj.org/article/1419e33c21fb4eecb42ff7ad547591de
Publikováno v:
Diagnostics, Vol 13, Iss 4, p 691 (2023)
Objectives: To investigate the predictive ability of clinical and chest computed tomography (CT) features to predict the severity of symptomatic immune checkpoint inhibitor-related pneumonitis (CIP). Methods: This study included 34 patients diagnosed
Externí odkaz:
https://doaj.org/article/def18a1246064a70addbad1ebef58341
Autor:
Jun Zhao, Liang Zhao, Wei Guo, Shuhang Wang, Xiuli Tao, Lin Li, Yousheng Mao, Fengwei Tan, Yushun Gao, Ning Wu, Jianming Ying, Qi Xue, Ning Li, Shugeng Gao, Jie He
Publikováno v:
Journal of Thoracic Oncology. 18:780-791
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2323f788a8c20d044120f7b6fa5245a2
https://doi.org/10.1016/j.jtho.2023.02.019
https://doi.org/10.1016/j.jtho.2023.02.019
Autor:
Donghui Hou, Xiaomin Zheng, Wei Song, Xiaoqing Liu, Sicong Wang, Lina Zhou, Xiuli Tao, Lv Lv, Qi Sun, Yujing Jin, Zewei Zhang, Lieming Ding, Ning Wu, Shijun Zhao
Publikováno v:
Acta Radiologica. 64:1194-1204
Background The prognosis of lung cancer varies widely, even in cases wherein the tumor stage, genetic mutation, and treatment regimens are the same. Thus, an effective means for risk stratification of patients with lung cancer is needed. Purpose To d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c4ad043be97d5d8eb64f012652c708c
https://doi.org/10.1177/02841851221119621
https://doi.org/10.1177/02841851221119621
Autor:
Zhuoxin Ye, Yibing Liu, Meichen Pan, Xiuli Tao, Yuxuan Chen, Pinyi Ma, Ying Zhuo, Daqian Song
Publikováno v:
Biosensors and Bioelectronics. 228:115219
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::317d9b51a654620c67a5e9d72372f032
https://doi.org/10.1016/j.bios.2023.115219
https://doi.org/10.1016/j.bios.2023.115219
Autor:
Bing Wang, Jun Zhao, Fan Zhang, Xiuli Tao, Jie He, Shun He, Ning Wu, Yun Ling, Shugeng Gao, Nan Sun, Dali Wang, Fang Lv, Kai Su, S. Gao, Kang Shao, Wendong Lei, Shuhang Wang, Yue Yu, Dawei Wu, Qi Xue, Wei Tang, Lei Zhang, Zhijie Wang, Fengwei Tan, Liang Zhao, Ziran Zhao, Ning Li, Jianming Ying, Yibo Gao, Yousheng Mao, Chunjian Duan, Jie Wang
Publikováno v:
Journal of Thoracic Oncology. 15:816-826
Programmed death receptor-1 (PD-1) inhibitors have shown efficacy in first-line treatment of NSCLC; however, evidence of PD-1 inhibitor as neoadjuvant treatment is limited. This is a phase 1b study to evaluate the safety and outcome of PD-1 inhibitor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9abb5b08ed20a796977a3de15063910d
https://doi.org/10.1016/j.jtho.2020.01.017
https://doi.org/10.1016/j.jtho.2020.01.017
Autor:
Zewei Zhang, Shugeng Gao, Xiuli Tao, Jie Wang, Ning Wu, Shuhang Wang, Wei Tang, Jie He, Jianming Ying, Zhijie Wang, Ning Li, Yun Ling
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
Purpose Investigate whether 18F-FDG PET-CT has the potential to predict the major pathologic response (MPR) to neoadjuvant sintilimab in resectable NSCLC patients, and the potential of sifting patients who probably benefit from immunotherapy. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbd7e8f81133c65f2e3d6664885964e1
http://europepmc.org/articles/PMC7101299
http://europepmc.org/articles/PMC7101299
Autor:
Ning Wu, Zewei Zhang, Shijun Zhao, Xiaomin Zheng, Lv Lv, Lieming Ding, Qi Sun, Sicong Wang, Yu-Jing Jin, Xiuli Tao, Lina Zhou, Donghui Hou, Wei Song, Xiaoqing Liu
Publikováno v:
Thoracic Cancer
Thoracic Cancer, Vol 12, Iss 17, Pp 2388-2399 (2021)
Thoracic Cancer, Vol 12, Iss 17, Pp 2388-2399 (2021)
Background Here, we aimed to assess the association of ALK variants and alterations with ensartinib response duration in NSCLC, and explore the potential value of computed tomography (CT) radiomic features in predicting progression‐free survival (P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf8c64c8dc730779dbbe68ab22c683b3
https://pubmed.ncbi.nlm.nih.gov/34288491
https://pubmed.ncbi.nlm.nih.gov/34288491